Diabetes Drug Alogliptin Plus Combos Approved in EuropeDiabetes Drug Alogliptin Plus Combos Approved in Europe

The European Commission grants marketing authorization to the DPP-4 inhibitor alogliptin alone and in fixed-dose combination with either metformin or pioglitazone. International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news